Patent details
EP4003314
Title:
FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS USEFUL FOR THE PREVENTION OR TREATMENT OF DISEASE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Unitary Effect
Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
16/07/2024
Unitary Effect Status:
Unitary Effect Registered
Request Unitary Effect Accepted:
02/09/2024
Unitary Effect Date:
10/07/2024
Unitary Effect Registration Date:
02/09/2024
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
UPP register:
EP4003314
SPC Number:
Creation Date:
Basic Information
Publication number:
EP4003314
WO Application Number:
US2020043274
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP20848591.2
WO Publication Number:
WO2021021563
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
23/07/2020
Grant date:
10/07/2024
EP Publication Date:
01/06/2022
WO Publication Date:
04/02/2021
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
10/07/2024
EP B1 Publication Date:
10/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
22/07/2040
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
10/07/2024
Name:
Espervita Therapeutics, Inc.
Address:
7939 Secretariat Drive, Saline, Michigan 48176, United States of America (US)
Inventor
Name:
ONICIU, Daniela Carmen
Address:
Gainesville, Florida 32605, United States of America (US)
Priority
1
Priority Patent Number:
201962901739 P
Priority Date:
17/09/2019
Priority Country:
United States of America (US)
2
Priority Patent Number:
201962878852 P
Priority Date:
26/07/2019
Priority Country:
United States of America (US)
Classification
IPC or IDT classification:
C07C 57/34 ;
C07C 61/39 ;
A61K 31/047 ;
A61K 31/192 ;
A61K 31/194 ;
Publication
Bulletin
1
Bulletin Heading:
UP1
Journal edition number:
40/24
Publication date:
02/10/2024
Description:
European patents with registered Unitary Effect
2
Bulletin Heading:
EP2
Journal edition number:
28/24
Publication date:
10/07/2024
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202440
Publication date:
02/10/2024
Description:
Unitary Effect Request Acceptance
2
Issue number:
202434
Publication date:
21/08/2024
Description:
Unitary Effect Request Receipt
3
Issue number:
202432
Publication date:
07/08/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed
4
Issue number:
202428
Publication date:
10/07/2024
Description:
Grant (B1)
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type